Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹31.4Prev. Close
₹31.31Turnover(Lac.)
₹134.78Day's High
₹32.05Day's Low
₹31.3152 Week's High
₹45.752 Week's Low
₹19.8Book Value
₹47.69Face Value
₹1Mkt Cap (₹ Cr.)
704.63P/E
142.82EPS
0.22Divi. Yield
026 May 2023
12:00 AM
AGM
Announcement Date: 26 May, 2023
8 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
26 May 2023
12:00 AM
BookCloser
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 22.43 | 22.43 | 22.43 | 22.43 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,042.17 | 1,064.44 | 1,038.31 | 1,112.18 |
Net Worth | 1,064.6 | 1,086.87 | 1,060.74 | 1,134.61 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 1,541.82 | 2,362.8 | 1,875.53 | 1,643.33 |
yoy growth (%) | -34.74 | 25.98 | 14.12 | -1.96 |
Raw materials | -1,155.61 | -1,857.58 | -1,366.48 | -1,154.16 |
As % of sales | 74.95 | 78.61 | 72.85 | 70.23 |
Employee costs | -73.37 | -80.99 | -78.4 | -79.23 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -59.33 | 35.74 | 62.56 | 67.21 |
Depreciation | -60.25 | -60.76 | -64.3 | -62.25 |
Tax paid | 11.5 | -5.68 | -10.41 | -12.07 |
Working capital | -198.01 | -62.6 | 154.59 | -9.65 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -34.74 | 25.98 | 14.12 | -1.96 |
Op profit growth | -49.92 | -7.65 | 5.27 | -6.12 |
EBIT growth | -67.38 | -9.11 | -3.71 | -1.38 |
Net profit growth | -343.32 | -42.36 | -5.4 | 1.47 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 1,925.83 | 1,746.56 | 1,925.52 | 1,763.74 | 2,642.86 |
Excise Duty | 241.75 | 222.89 | 256.69 | 220.44 | 276.48 |
Net Sales | 1,684.09 | 1,523.67 | 1,668.83 | 1,543.3 | 2,366.38 |
Other Operating Income | 1.55 | 0.94 | 0.03 | 1.07 | 0.36 |
Other Income | 13.03 | 42.24 | 11.29 | 2.72 | 4.01 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,528.3 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,565 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,476.4 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,090.75 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,497.2 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Sanjiv Goyal
Independent Director
Ajay Swaroop
Nominee
Meena Verma
Independent Director
Rupinder Tewari
Company Sec. & Compli. Officer
Anubha
Independent Director
Kuldip Kumar Bhasin
Independent Director
Indu Pal Kaur
Director (Operation)
Puneet Sud
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Nectar Lifescience Ltd
Summary
Nectar Lifesciences Ltd (NLL or NECLIFE) is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products. The company manufactures Cephalosporin Active pharmaceutical ingredients, finished dosage forms, Phytochemicals, and hard gelatin capsules at their facilities spread across three Indian states of Punjab, Himachal Pradesh and Jammu. They have developed sustainable production systems to manufacture high quality intermediates and APIs to meet the diverse requirements of their customer base in India and over 90 countries worldwide. The companys business operations are primarily concentrated on manufacturing and marketing of oral and sterile cephalosporins, phytochemicals and allied products. They manufacture and sell a range of cephalosporins and phytochemicals. They are also engaged in contract manufacturing of APIs for pharmaceutical players.Nectar Lifesciences Ltd was incorporated on June 27, 1995 as a public limited company with the name Surya Medicare Ltd. The company was established pursuant to a financial collaboration agreement between the Promoters and Punjab State Industrial Development Corporation.In April 1997, the company commenced business with the commercial production of Oral Bulk Drugs at their manufacturing facility located in the B Category zone of Punjab. In March 1998, they started the production of Sterile Bulk Drugs. In the year 1999, they added the formulation facilities by setting up a vial fi
Read More
What is the Nectar Lifescience Ltd share price today?
The Nectar Lifescience Ltd shares price on nse is Rs.₹31.42 today.
What is the Market Cap of Nectar Lifescience Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Nectar Lifescience Ltd is ₹704.63 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Nectar Lifescience Ltd?
The PE and PB ratios of Nectar Lifescience Ltd is 142.82 and 0.66 as of 03 Jul ‘24
What is the 52 Week High and Low of Nectar Lifescience Ltd?
The 52-week high/low is the highest and lowest price at which a Nectar Lifescience Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Nectar Lifescience Ltd is ₹19.8 and ₹45.7 as of 03 Jul ‘24
What is the CAGR of Nectar Lifescience Ltd?
Nectar Lifescience Ltd's CAGR for 5 Years at 16.09%, 3 Years at -8.11%, 1 Year at 54.62%, 6 Month at -9.51%, 3 Month at -13.75% and 1 Month at -3.07%.
What is the shareholding pattern of Nectar Lifescience Ltd?
The shareholding pattern of Nectar Lifescience Ltd is as follows:
Promoters - 44.35 %
Institutions - 13.51 %
Public - 21.63 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
